“There has to be more caring”: patient and care partner experiences of the disclosure of amyloid-β PET scan results

References

• Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., Snyder, P. J., Carrillo, M. C., Thies, B., & Phelps, C. H. (2013). The diagnosis of mild cognitive impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on diagnostic guidelines for Alzheimer’s Disease. FOCUS, 11(1), 96–106. https://doi.org/10.1176/appi.focus.11.1.96
   Google Scholar
• Alzheimer’s Association. (2022). 2022 Alzheimer’s Disease facts and figures. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 18(4), 700–789.
   PubMed Web of Science ®Google Scholar
• Beach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012). Accuracy of the clinical diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010. Journal of Neuropathology and Experimental Neurology, 71(4), 266–273. https://doi.org/10.1097/NEN.0b013e31824b211b
   PubMed Web of Science ®Google Scholar
• Belanger, E., D’Silva, J., Carroll, M. S., Van Houtven, C. H., Shepherd-Banigan, M., Smith, V. A., & Wetle, T. T. (2022). Reactions to Amyloid PET Scan Results and Levels of Anxious and Depressive Symptoms: CARE IDEAS Study. The Gerontologist, no. (Belanger, D’Silva, Carroll, Wetle) Center for Gerontology and Healthcare Research, Brown University, School of Public Health, Providence, RI, USA(Belanger, Wetle) Department of Health Services, Policy & Practice, Brown University, School of Public Health. https://doi.org/10.1093/geront/gnac051
   Google Scholar
• Blennow, K., & Zetterberg, H. (2018). Biomarkers for Alzheimer’s Disease: Current Status and prospects for the future. Journal of Internal Medicine, 284(6), 643–663. https://doi.org/10.1111/joim.12816
   PubMed Web of Science ®Google Scholar
• Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
   Google Scholar
• Byszewski, A. M., Molnar, F. J., Aminzadeh, F., Eisner, M., Gardezi, F., & Bassett, R. (2007). Dementia diagnosis disclosure: A study of patient and caregiver perspectives. Alzheimer Disease and Associated Disorders, 21(2), 107–114. https://doi.org/10.1097/WAD.0b013e318065c481
   PubMed Web of Science ®Google Scholar
• Connell, C. M., Boise, L., Stuckey, J. C., Holmes, S. B., & Hudson, M. L. (2004). Attitudes toward the diagnosis and disclosure of Dementia among family caregivers and primary care physicians. The Gerontologist, 44(4), 500–507. https://doi.org/10.1093/geront/44.4.500
   PubMed Web of Science ®Google Scholar
• Couch, E., Ashford, M. T., Zhang, W., & Prina, M. (2023). Psychosocial and behavioral outcomes for persons with cognitive impairment and caregivers following Amyloid-β PET scan disclosure: A systematic review. Alzheimer Disease and Associated Disorders, 37(3), 246–258. https://doi.org/10.1097/WAD.0000000000000569
   PubMed Web of Science ®Google Scholar
• Couch, E., Belanger, E., Gadbois, E. A., DePasquale, N., Zhang, W., & Wetle, T. (2022). I know that my role is going to change’: A mixed-methods study of the relationship between Amyloid-β PET scan results and caregiver burden. Aging Clinical and Experimental Research, 35(2), 387–397. https://doi.org/10.1007/s40520-022-02314-6
   PubMed Web of Science ®Google Scholar
• Couch, E., Co, M., Albertyn, C. P., Prina, M., & Lawrence, V. (2024). A qualitative study of informal caregiver perceptions of the benefits of an early Dementia diagnosis. BMC Health Services Research, 24(1), 508. https://doi.org/10.1186/s12913-024-10957-6
   PubMed Web of Science ®Google Scholar
• Dubois, B., Padovani, A., Scheltens, P., Rossi, A., & Dell’Agnello, G. (2016). Timely diagnosis for Alzheimer’s Disease: A literature review on benefits and challenges. Journal of Alzheimer’s Disease: JAD, 49(3), 617–631. https://doi.org/10.3233/JAD-150692
   PubMed Web of Science ®Google Scholar
• Fruijtier, A. D., van der Schaar, J., van Maurik, I. S., Zwan, M. D., Scheltens, P., Bouwman, F., Pijnenburg, Y. A. L., et al. (2022). Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 19(1), 285–295. https://doi.org/10.1002/alz.12630
   PubMed Web of Science ®Google Scholar
• Gadbois, E. A., Bélanger, E., Shield, R. R., Plassman, B. L., Van Houtven, C. H., & Wetle, T. F. (2022). ‘Now at least we have something to call it’: Patient and care partner experiences receiving an Amyloid PET scan. Journal of the American Geriatrics Society, 70(10), 2938–2947. https://doi.org/10.1111/jgs.17937
   PubMed Web of Science ®Google Scholar
• Gale, S. A., Heidebrink, J., Grill, J., Graff-Radford, J., Jicha, G. A., Menard, W., Nowrangi, M., Sami, S., Sirivong, S., Walter, S., & Karlawish, J. (2022). Preclinical Alzheimer Disease and the electronic health record: Balancing confidentiality and care. Neurology, 99(22), 987–994. https://doi.org/10.1212/WNL.0000000000201347
   PubMed Web of Science ®Google Scholar
• Georgakas, J. E., Howe, M. D., Thompson, L. I. (2023). Biomarkers of Alzheimer’s Disease: Past, present and future clinical use. Biomarkers in. https://www.sciencedirect.com/science/article/pii/S2666144623000035.
   Google Scholar
• Grill, J. D., Apostolova, L. G., Bullain, S., Burns, J. M., Cox, C. G., Dick, M., Hartley, D., Kawas, C., Kremen, S., Lingler, J., Lopez, O. L., Mapstone, M., Pierce, A., Rabinovici, G., Roberts, J. S., Sajjadi, S. A., Teng, E., & Karlawish, J. (2017). Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimer’s Research & Therapy, 9(1), 35. https://doi.org/10.1186/s13195-017-0261-y
   PubMedGoogle Scholar
• Grill, J. D., Cox, C. G., Kremen, S., Mendez, M. F., Teng, E., Shapira, J., Ringman, J. M., & Apostolova, L. G. (2017). Patient and caregiver reactions to clinical amyloid imaging. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 13(8), 924–932. https://doi.org/10.1016/j.jalz.2017.01.001
   PubMed Web of Science ®Google Scholar
• Henderson, J. T., Martin, A., Patnode, C. D., & Henrikson, N. B. (2023). A synthesis of qualitative studies on patient and caregiver experiences with cognitive impairment screening and diagnosis. Aging & Mental Health, 27(8), 1506–1517. https://doi.org/10.1080/13607863.2022.2126431
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Jr, Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Budd Haeberlein, S., Holtzman, D. M., et al. (2018). NIA-AA research framework: Toward a biological definition of Alzheimer’s Disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 14(4), 535–562.
   PubMed Web of Science ®Google Scholar
• James, H. J., Van Houtven, C. H., Lippmann, S., Burke, J. R., Shepherd-Banigan, M., Belanger, E., Wetle, T. F., & Plassman, B. L. (2020). How accurately do patients and their care partners report results of Amyloid-Beta PET scans for Alzheimer’s Disease assessment? Journal of Alzheimer’s Disease: JAD, 74(2), 625–636. https://doi.org/10.3233/JAD-190922
   PubMed Web of Science ®Google Scholar
• Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., Alexander, M., Almdahl, I. S., Arnold, S. E., Baldeiras, I., Barthel, H., van Berckel, B. N. M., Bibeau, K., Blennow, K., Brooks, D. J., … Zetterberg, H; Amyloid Biomarker Study Group. (2015). Prevalence of cerebral amyloid pathology in persons without Dementia: A meta-analysis. JAMA: The Journal of the American Medical Association, 313(19), 1924–1938. https://doi.org/10.1001/jama.2015.4668
   PubMed Web of Science ®Google Scholar
• Johnson, K. A., Minoshima, S., Bohnen, N. I., Donohoe, K. J., Foster, N. L., Herscovitch, P., Karlawish, J. H., Rowe, C. C., Hedrick, S., Pappas, V., Carrillo, M. C., & Hartley, D. M. (2013). Update on appropriate use criteria for Amyloid PET imaging: Dementia experts, mild cognitive impairment, and education. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 54(7), 1011–1013. https://doi.org/10.2967/jnumed.113.127068
   PubMed Web of Science ®Google Scholar
• Jutkowitz, E., Van Houtven, C. H., Plassman, B. L., & Mor, V. (2020). Willingness to undergo a risky treatment to improve cognition among persons with cognitive impairment who received an Amyloid PET Scan. Alzheimer Disease and Associated Disorders, 34(1), 1–9. https://doi.org/10.1097/WAD.0000000000000338
   PubMed Web of Science ®Google Scholar
• Kissel, E. C., & Carpenter, B. D. (2007). It’s all in the details: Physician variability in disclosing a dementia diagnosis. Aging & Mental Health, 11(3), 273–280. https://doi.org/10.1080/13607860600963471
   PubMed Web of Science ®Google Scholar
• Largent, E. A., & Bradbury, A. R. (2022). Bringing Alzheimer Disease testing and results disclosure into the 21st Century Cures Act. JAMA Neurology, 79(3), 219–220. https://doi.org/10.1001/jamaneurol.2021.4851
   PubMed Web of Science ®Google Scholar
• Largent, E. A., Grill, J. D., O’Brien, K., Wolk, D., Harkins, K., & Karlawish, J. (2023). Testing for Alzheimer Disease biomarkers and disclosing results across the disease continuum. Neurology, 100(21), 1010–1019. https://doi.org/10.1212/WNL.0000000000206891
   PubMed Web of Science ®Google Scholar
• Laver, K., Liu, E., Clemson, L., Davies, O., Gray, L., Gitlin, L. N., & Crotty, M. (2020). Does telehealth delivery of a dyadic dementia care program provide a noninferior alternative to face-to-face delivery of the same program? A randomized, controlled trial. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 28(6), 673–682. https://doi.org/10.1016/j.jagp.2020.02.009
   PubMed Web of Science ®Google Scholar
• Lee, J. J. Y., Barlas, J., Thompson, C. L., & Dong, Y. H. (2018). Caregivers’ experience of decision-making regarding diagnostic assessment following cognitive screening of older adults. Journal of Aging Research, 2018(December), 8352816–8352819. https://doi.org/10.1155/2018/8352816
   PubMedGoogle Scholar
• Lingler, J. H., Sereika, S. M., Butters, M. A., Cohen, A. D., Klunk, W. E., Knox, M. L., McDade, E., Nadkarni, N. K., Roberts, J. S., Tamres, L. K., & Lopez, O. L. (2020). A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 16(9), 1330–1337. https://doi.org/10.1002/alz.12129
   PubMed Web of Science ®Google Scholar
• McCleery, J., Laverty, J., & Quinn, T. J. (2021). Diagnostic test accuracy of telehealth assessment for Dementia and mild cognitive impairment. The Cochrane Database of Systematic Reviews, 7(7), CD013786. https://doi.org/10.1002/14651858.CD013786.pub2
   PubMedGoogle Scholar
• Poyser, C. A., & Tickle, A. (2019). Exploring the experience of the disclosure of a Dementia diagnosis from a clinician, patient and carer perspective: A systematic review and meta-ethnographic synthesis. Aging & Mental Health, 23(12), 1605–1615. https://doi.org/10.1080/13607863.2018.1506747
   PubMed Web of Science ®Google Scholar
• Prince, M., Bryce, R., & Ferri, C. (2011). “World Alzheimer Report 2011: The Benefits of Early Diagnosis and Intervention.”
   Google Scholar
• Rabinovici, G. D., Gatsonis, C., Apgar, C., Chaudhary, K., Gareen, I., Hanna, L., Hendrix, J., Hillner, B. E., Olson, C., Lesman-Segev, O. H., Romanoff, J., Siegel, B. A., Whitmer, R. A., & Carrillo, M. C. (2019). Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or Dementia. JAMA: The Journal of the American Medical Association, 321(13), 1286–1294. https://doi.org/10.1001/jama.2019.2000
   PubMed Web of Science ®Google Scholar
• Robinson, L., Clare, L., & Evans, K. (2005). Making sense of Dementia and adjusting to loss: Psychological reactions to a diagnosis of Dementia in couples. Aging & Mental Health, 9(4), 337–347. https://doi.org/10.1080/13607860500114555
   PubMed Web of Science ®Google Scholar
• Saragih, I. D., Tonapa, S. I., Porta, C. M., & Lee, B.-O. (2022). Effects of telehealth intervention for people with Dementia and their carers: A systematic review and meta-analysis of randomized controlled studies. Journal of Nursing Scholarship: An Official Publication of Sigma Theta Tau International Honor Society of Nursing, 54(6), 704–719. https://doi.org/10.1111/jnu.12797
   PubMed Web of Science ®Google Scholar
• Vanderschaeghe, G., Schaeverbeke, J., Bruffaerts, R., Vandenberghe, R., & Dierickx, K. (2017). Amnestic MCI patients’ experiences after disclosure of their Amyloid PET result in a research context. Alzheimer’s Research & Therapy, 9(1), 92.
   PubMedGoogle Scholar
• Welsh, K. A., John, C., Breitner., & K. M., Magruder-Habib. (1993). Detection of Dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 6(2), 103–110.
   Google Scholar